Edition:
United Kingdom

Evofem Biosciences Inc (EVFM.OQ)

EVFM.OQ on NASDAQ Stock Exchange Capital Market

6.20USD
20 Apr 2018
Change (% chg)

$-0.07 (-1.12%)
Prev Close
$6.27
Open
$6.23
Day's High
$6.25
Day's Low
$6.05
Volume
2,176
Avg. Vol
5,407
52-wk High
$15.60
52-wk Low
$1.80

Chart for

About

Evofem Biosciences Inc, formerly Neothetics, Inc., is a clinical-stage specialty pharmaceutical company, which develops therapeutics. The Company focuses on localized fat reduction and body contouring. It focuses on the development of LIPO-202 for the reduction of central abdominal bulging due to subcutaneous fat in non-obese... (more)

Overall

Beta: --
Market Cap(Mil.): $6.33
Shares Outstanding(Mil.): 13.83
Dividend: --
Yield (%): --

Financials

  EVFM.OQ Industry Sector
P/E (TTM): -- 30.95 32.74
EPS (TTM): -0.74 -- --
ROI: -80.14 14.84 14.38
ROE: -90.12 16.34 16.07

BRIEF-Evofem Biosciences Receives Fast Track Designation For Amphora For Prevention Of Chlamydia

* EVOFEM BIOSCIENCES RECEIVES FAST TRACK DESIGNATION FOR AMPHORA FOR PREVENTION OF CHLAMYDIA

21 Feb 2018

Earnings vs. Estimates